Cytokinetics, Incorporated (CYTK) financial statements (2020 and earlier)

Company profile

Business Address 280 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA 94080
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:1671992851641128380
Cash and cash equivalents404212567652020
Short-term investments12715614489466358
Other undisclosed cash, cash equivalents, and short-term investments (0)1780(0)2
Receivables7210047 
Contract with customer, asset 5
Other current assets     12
Other undisclosed current assets32(12)(5)10(2)
Total current assets:17720827415911313179
Noncurrent Assets
Property, plant and equipment4344221
Long-term investments and receivables  1780 3
Long-term investments  1780 3
Other noncurrent assets7000000
Total noncurrent assets:1142112224
TOTAL ASSETS:18721129517011513383
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities17202322111012
Accounts payable3454214
Accrued liabilities13161718858
Employee-related liabilities     4 
Debt53 3   
Deferred revenue and credits108211715
Other liabilities000    
Other undisclosed current liabilities   0 (4) 
Total current liabilities:22223233322427
Noncurrent Liabilities
Long-term debt and lease obligation4840322715  
Long-term debt, excluding current maturities4540322715  
Operating lease, liability3
Liabilities, other than long-term debt 116150172
Deferred revenue and credits15150172
Other liabilities 11    
Other undisclosed noncurrent liabilities138122105    
Total noncurrent liabilities:1861631534315172
Total liabilities:20718518576474129
Stockholders' equity
Stockholders' equity attributable to parent(20)2611094699254
Common stock0000000
Additional paid in capital814769756612603589537
Accumulated other comprehensive income (loss)11000(0)0
Accumulated deficit(834)(743)(646)(518)(535)(497)(483)
Total stockholders' equity:(20)2611094699254
TOTAL LIABILITIES AND EQUITY:18721129517011513383

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues313213106294731
Revenue, net910104
Cost of revenue      (0)
Gross profit:313213106294731
Operating expenses(128)(120)(127)(88)(66)(62)(64)
Operating income (loss):(97)(89)(113)19(37)(15)(34)
Nonoperating income (expense)4430(0)00
Investment income, nonoperating3  0001
Interest and debt expense(5)(4)(3)(3)(0) 0
Other undisclosed loss from continuing operations before equity method investments, income taxes      (0)
Income (loss) from continuing operations before equity method investments, income taxes:(98)(89)(114)16(38)(15)(34)
Other undisclosed income (loss) from continuing operations before income taxes(18)(18)(14) 0  
Income (loss) before gain (loss) on sale of properties:(115)(106)(128)16(38)(15)(34)
Other undisclosed net income8      
Net income (loss):(107)(106)(128)16(38)(15)(34)
Other undisclosed net loss attributable to parent(10)      
Net income (loss) available to common stockholders, diluted:(118)(106)(128)16(38)(15)(34)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(107)(106)(128)16(38)(15)(34)
Other comprehensive income (loss)000(0)0(0)(0)
Comprehensive income (loss):(107)(106)(128)16(37)(15)(34)
Other undisclosed comprehensive loss, net of tax, attributable to parent(10)      
Comprehensive income (loss), net of tax, attributable to parent:(117)(106)(128)16(37)(15)(34)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: